Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Psyence Biomedical Ltd (NASDAQ: PBM) closed the day trading at $4.54 up 92.37% from the previous closing price of $2.36. In other words, the price has increased by $92.37 from its previous closing price. On the day, 55.51 million shares were traded. PBM stock price reached its highest trading level at $5.8 during the session, while it also had its lowest trading level at $3.8127.
Ratios:
For a better understanding of PBM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.64 and its Current Ratio is at 0.64.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBM now has a Market Capitalization of 3238073 and an Enterprise Value of -5811600.
Stock Price History:
The Beta on a monthly basis for PBM is 0.32, which has changed by -0.9850756 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, PBM has reached a high of $343.71, while it has fallen to a 52-week low of $2.36. The 50-Day Moving Average of the stock is -16.23%, while the 200-Day Moving Average is calculated to be -68.54%.
Shares Statistics:
Over the past 3-months, PBM traded about 747.23K shares per day on average, while over the past 10 days, PBM traded about 9669930 shares per day. Insiders hold about 0.00% of the company’s shares, while institutions hold 46.56% stake in the company. Shares short for PBM as of 1752537600 were 12872 with a Short Ratio of 0.02, compared to 1749772800 on 15310. Therefore, it implies a Short% of Shares Outstanding of 12872 and a Short% of Float of 1.83.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
